Annals of Surgical Oncology

, Volume 26, Issue 10, pp 3133–3140 | Cite as

A Comparison of Patient-Reported Outcomes After Breast-Conserving Surgery and Mastectomy with Implant Breast Reconstruction

  • Meghan R. Flanagan
  • Emily C. Zabor
  • Anya Romanoff
  • Sarah Fuzesi
  • Michelle Stempel
  • Babak J. Mehrara
  • Monica Morrow
  • Andrea L. Pusic
  • Mary L. GemignaniEmail author
Breast Oncology



Many factors influence decisions regarding choice of breast-conserving surgery (BCS) versus mastectomy with reconstruction for early invasive breast cancer. The purpose of this study was to compare patient satisfaction following BCS and mastectomy with implant reconstruction (M-iR) utilizing the BREAST-Q patient-reported outcome measure.


Women with stage I or II breast cancer undergoing BCS or M-iR who completed a BREAST-Q from 2010 to 2016 were identified by retrospective review of a prospective database. Baseline characteristics were compared, and linear mixed models were used to analyze associations with BREAST-Q scores over time.


Our study group was composed of 3233 women; 2026 (63%) had BCS, 123 (3.8%) had nipple-sparing mastectomy, and 1084 (34%) had skin-sparing or total mastectomy. Median time from surgery to BREAST-Q was 205 days for BCS and 639 days for M-iR (p < 0.001). Regardless of type of surgery, breast satisfaction scores decreased significantly over time (p < 0.001), whereas psychosocial (p = 0.001) and sexual (p = 0.004) well-being scores increased significantly over time. BCS was associated with significantly higher scores over time compared with M-iR across all subscales (all p < 0.001). Radiation was significantly associated with decreased scores over time across all subscales (all p < 0.05).


Breast satisfaction and quality-of-life scores were higher for BCS compared with M-iR in early-stage invasive breast cancer. These findings may help in counseling women who have a choice for surgical treatment. Breast satisfaction scores decreased over time in all women, highlighting the need for further evaluation with longer follow-up.



The preparation of this manuscript was funded in part by NIH/NCI Cancer Center Support Grant No. P30 CA008748 to Memorial Sloan Kettering Cancer Center, and this study was presented in podium format at the 20th Annual Meeting of the American Society of Breast Surgeons, April 30–May 5, 2019, Dallas, TX. Dr. Babak Mehrara has received salary support for a research project sponsored by aTyr Corporation, and Dr. Monica Morrow has received speaking honoraria from Genomic Health and Roche. Dr. Andrea Pusic is a co-developer of the BREAST-Q and receives royalties when the questionnaire is used in for-profit industry-sponsored clinical trials.


  1. 1.
    Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Darby S, McGale P, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707–16.CrossRefGoogle Scholar
  2. 2.
    Anderson SJ, Wapnir I, Dignam JJ, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol. 2009;27(15):2466–73.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Zumsteg ZS, Morrow M, Arnold B, et al. Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer. Ann Surg Oncol. 2013;20(11):3469–76.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    El-Tamer MB, Ward BM, Schifftner T, Neumayer L, Khuri S, Henderson W. Morbidity and mortality following breast cancer surgery in women: national benchmarks for standards of care. Ann Surg. 2007;245(5):665–71.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Jonczyk MM, Jean J, Graham R, Chatterjee A. Trending towards safer breast cancer surgeries? Examining acute complication rates from a 13-year NSQIP analysis. Cancers (Basel). 2019. Scholar
  6. 6.
    Kummerow KL, Du L, Penson DF, Shyr Y, Hooks MA. Nationwide trends in mastectomy for early-stage breast cancer. JAMA Surg. 2015;150(1):9–16.CrossRefGoogle Scholar
  7. 7.
    Albornoz CR, Matros E, Lee CN, et al. Bilateral mastectomy versus breast-conserving surgery for early-stage breast cancer: the role of breast reconstruction. Plast Reconstr Surg. 2015;135(6):1518–26.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Jagsi R, Jiang J, Momoh AO, et al. Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States. J Clin Oncol. 2014;32(9):919–26.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Sabino J, Lucas DJ, Shriver CD, Vertrees AE, Valerio IL, Singh DP. NSQIP analysis: increased immediate reconstruction in the treatment of breast cancer. Am Surg. 2016;82(6):540–5.PubMedGoogle Scholar
  10. 10.
    Pusic AL, Matros E, Fine N, et al. Patient-reported outcomes 1 year after immediate breast reconstruction: results of the mastectomy reconstruction outcomes consortium study. J Clin Oncol. 2017;35(22):2499–506.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Momoh AO, Cohen WA, Kidwell KM, et al. Tradeoffs associated with contralateral prophylactic mastectomy in women choosing breast reconstruction: results of a prospective multicenter cohort. Ann Surg. 2017;266(1):158–64.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Atisha DM, Tessiatore KM, Rushing CN, Dayicioglu D, Pusic A, Hwang S. A national snapshot of patient-reported outcomes comparing types of abdominal flaps for breast reconstruction. Plast Reconstr Surg. 2019;143(3):667–77.CrossRefPubMedGoogle Scholar
  13. 13.
    Cano SJ, Klassen AF, Scott AM, Cordeiro PG, Pusic AL. The BREAST-Q: further validation in independent clinical samples. Plast Reconstr Surg. 2012;129(2):293–302.CrossRefPubMedGoogle Scholar
  14. 14.
    Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ. Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg. 2009;124(2):345–53.CrossRefPubMedGoogle Scholar
  15. 15.
    BREAST-Q Website. Accessed 6 May 2019.
  16. 16.
    Romanoff A, Zabor EC, Stempel M, Sacchini V, Pusic A, Morrow M. A comparison of patient-reported outcomes after nipple-sparing mastectomy and conventional mastectomy with reconstruction. Ann Surg Oncol. 2018;25(10):2909–16.CrossRefPubMedGoogle Scholar
  17. 17.
    Nichols HB, Berrington de Gonzalez A, Lacey JV Jr, Rosenberg PS, Anderson WF. Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol. 2011;29(12):1564–9.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Tuttle TM, Jarosek S, Habermann EB, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27(9):1362–7.CrossRefPubMedGoogle Scholar
  19. 19.
    King TA, Sakr R, Patil S, et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol. 2011;29(16):2158–64.CrossRefPubMedGoogle Scholar
  20. 20.
    Howes BH, Watson DI, Xu C, Fosh B, Canepa M, Dean NR. Quality of life following total mastectomy with and without reconstruction versus breast-conserving surgery for breast cancer: a case-controlled cohort study. J Plast Reconstr Aesthet Surg. 2016;69(9):1184–91.CrossRefPubMedGoogle Scholar
  21. 21.
    Cocquyt VF, Blondeel PN, Depypere HT, et al. Better cosmetic results and comparable quality of life after skin-sparing mastectomy and immediate autologous breast reconstruction compared to breast conservative treatment. Br J Plast Surg. 2003;56(5):462–70.CrossRefPubMedGoogle Scholar
  22. 22.
    Jagsi R, Li Y, Morrow M, et al. Patient-reported quality of life and satisfaction with cosmetic outcomes after breast conservation and mastectomy with and without reconstruction: results of a survey of breast cancer survivors. Ann Surg. 2015;261(6):1198–206.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Santosa KB, Qi J, Kim HM, Hamill JB, Wilkins EG, Pusic AL. Long-term patient-reported outcomes in postmastectomy breast reconstruction. JAMA Surg. 2018;153(10):891–9.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Chand ND, Browne V, Paramanathan N, Peiris LJ, Laws SA, Rainsbury RM. Patient-reported outcomes are better after oncoplastic breast conservation than after mastectomy and autologous reconstruction. Plast Reconstr Surg Glob Open. 2017;5(7):e1419.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Catsman C, Beek MA, Voogd AC, Mulder PGH, Luiten EJT. The COSMAM TRIAL a prospective cohort study of quality of life and cosmetic outcome in patients undergoing breast conserving surgery. BMC Cancer. 2018;18(1):456.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Rechis R, Boerner L, Nutt S, Shaw K, Berno D, Duchover Y. How cancer has affected post-treatment survivors: a LIVESTRONG report. 1–27. Accessed 10 Apr 2019.
  27. 27.
    Aerts L, Christiaens MR, Enzlin P, Neven P, Amant F. Sexual functioning in women after mastectomy versus breast conserving therapy for early-stage breast cancer: a prospective controlled study. Breast. 2014;23(5):629–36.CrossRefPubMedGoogle Scholar
  28. 28.
    Parker PA, Youssef A, Walker S, et al. Short-term and long-term psychosocial adjustment and quality of life in women undergoing different surgical procedures for breast cancer. Ann Surg Oncol. 2007;14(11):3078–89.CrossRefPubMedGoogle Scholar
  29. 29.
    Gass JS, Onstad M, Pesek S, et al. Breast-specific sensuality and sexual function in cancer survivorship: Does surgical modality matter? Ann Surg Oncol. 2017;24(11):3133–40.CrossRefPubMedGoogle Scholar
  30. 30.
    Avis NE, Crawford S, Manuel J. Psychosocial problems among younger women with breast cancer. Psychooncology. 2004;13(5):295–308.CrossRefPubMedGoogle Scholar
  31. 31.
    Ganz PA, Desmond KA, Belin TR, Meyerowitz BE, Rowland JH. Predictors of sexual health in women after a breast cancer diagnosis. J Clin Oncol. 1999;17(8):2371–80.CrossRefPubMedGoogle Scholar
  32. 32.
    Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE. Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol. 1998;16(2):501–14.CrossRefPubMedGoogle Scholar
  33. 33.
    Bentzen SM, Turesson I, Thames HD. Fractionation sensitivity and latency of telangiectasia after postmastectomy radiotherapy: a graded-response analysis. Radiother Oncol. 1990;18(2):95–106.CrossRefPubMedGoogle Scholar
  34. 34.
    Bentzen SM, Thames HD, Overgaard M. Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study. Radiother Oncol. 1989;15(3):267–74.CrossRefPubMedGoogle Scholar
  35. 35.
    Ricci JA, Epstein S, Momoh AO, Lin SJ, Singhal D, Lee BT. A meta-analysis of implant-based breast reconstruction and timing of adjuvant radiation therapy. J Surg Res. 2017;218:108–16.CrossRefPubMedGoogle Scholar
  36. 36.
    Turesson I. The progression rate of late radiation effects in normal tissue and its impact on dose–response relationships. Radiother Oncol. 1989;15(3):217–26.CrossRefPubMedGoogle Scholar
  37. 37.
    Albornoz CR, Matros E, McCarthy CM, et al. Implant breast reconstruction and radiation: a multicenter analysis of long-term health-related quality of life and satisfaction. Ann Surg Oncol. 2014;21(7):2159–64.CrossRefPubMedGoogle Scholar
  38. 38.
    Sinnott CJ, Persing SM, Pronovost M, Hodyl C, McConnell D, Ott Young A. Impact of postmastectomy radiation therapy in prepectoral versus subpectoral implant-based breast reconstruction. Ann Surg Oncol. 2018;25(10):2899–908.CrossRefPubMedGoogle Scholar
  39. 39.
    Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma. Accessed 10 Apr 2019.
  40. 40.
    Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), McGale P, Taylor C, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383(9935):2127–35.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  • Meghan R. Flanagan
    • 1
  • Emily C. Zabor
    • 2
  • Anya Romanoff
    • 1
  • Sarah Fuzesi
    • 1
  • Michelle Stempel
    • 1
  • Babak J. Mehrara
    • 3
  • Monica Morrow
    • 1
  • Andrea L. Pusic
    • 4
  • Mary L. Gemignani
    • 1
    Email author
  1. 1.Breast Service, Department of SurgeryMemorial Sloan Kettering Cancer CenterNew YorkUSA
  2. 2.Biostatistics Service, Department of Epidemiology and BiostatisticsMemorial Sloan Kettering Cancer CenterNew YorkUSA
  3. 3.Plastic and Reconstructive Surgical Service, Department of SurgeryMemorial Sloan Kettering Cancer CenterNew YorkUSA
  4. 4.Plastic and Reconstructive Surgery DivisionBrigham and Women’s HospitalBostonUSA

Personalised recommendations